Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Low Price/Cash Ratio Value Stocks -- Ignore unavailable to you. Want to Upgrade?

To: MCsweet who wrote (703)	3/6/2003 9:08:53 AM
From: Elroy	Respond to of 1931

Of those three ALPH looks the best to me (at a glance). Still, don't know what would turn the shares around other than an improvement in business fundamentals, but at a $1 million per Q burn or so you've got plenty of time to wait.

To: MCsweet who wrote (703)	3/6/2003 9:53:33 PM
From: stock leader	Read Replies (1) \| Respond to of 1931

I currently have some minor shares of DCRN at 1.01. It's selling at 40% cash levels with very little liabilities and low cash loss level of about 1.5 mill per qtr. It is a development stage biotech but i like the cheap valuation . there are alot of bio's trading well below cash levels though. Might be good idea just to buy a basket of them and hope at least 1 gets some buzz during the year.